Corporate News
Senores Pharmaceuticals Limited announced several strategic moves, including the appointments of Dr. Viranchi Arvindbhai Shah as Director, Shilpa Shah as Company Secretary, and Rajeev Kumar as Chief Financial Officer. The company’s board approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026, granting 4,72,000 options, representing 1% of equity, to eligible employees with a potential discount of up to 50% on the market price. Furthermore, Senores Pharmaceuticals is expanding its international operations by incorporating a wholly-owned subsidiary in Mexico to distribute pharmaceutical products and establishing a subsidiary in Canada, in which it will hold at least 51% ownership, both funded through cash investments. Regulatory approvals will be obtained as required by Mexican and Canadian law.